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Kajian Penggunaan Garispanduan Praktis Klinikal Pengurusan Diabetes Mellitus Jenis 2 
Di Kelantan. 
PENGENALAN 
Prevalen diabetes di Malaysia semakin meningkat dan kebanyakan pesakit dilaporkan 
mempunyai kawalan glukosa yang tidak baik. Garispanduan Praktis Klinikal (GPK) 
diwujudkan untuk memperbaiki pengendalian pesakit oleh kakitangan kesihatan bagi 
menghasilkan kesihatan yang baik kepada para pesakit. 
OBJEKTIF 
Objektif kajian ini adalah untuk menentukan penggunaan GPK diabetes di kalangan 
pasukan kawalan diabetes (PKD), mengkaji keberkesanan kursus intensif GPK yang 
diberikan kepada PKD ke atas pengetahuan, sikap dan amalan (PSA) mereka serta PSA 
dan kawalan diabetes pesakit mereka serta faktor-faktor yang berkaitan dengan paras 
HbA1c di kalangan pesakit diabetes dengan kawalan glukos yang tidak baik. 
KAEDAH 
Kajian ini dijalankan di semua klinik kesihatan (KK) di Kelantan dari Ogos 2005 
hingga Mac 2006. Kajian keratan rentas digunakan untuk menentukan penggunaan GPK 
dan faktor-faktor yang berkaitan dengan paras HbAtc di kalangan pesakit diabetes. 
Kajian kawalan secara rawak digunakan untuk menentukan kesan intervensi ke atas 
PSA PKD serta PSA dan kawalan diabetes pesakit mereka. Kumpulan intervensi dan 
.. 
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kumpulan kawalan dipilih secara rawak berdasarkan daerah atau jajahan di negeri 
Kelantan. Pengukuran semula dibuat selepas empat bulan intervensi dijalankan. 
KEPUTUSAN 
Sejumlah 176 PKD menyertai kajian ini. Dari segi penggunaan GPK, cuma 40.4% 
hingga 83.1% mengaku selalu melakukan mana-mana proses pengendalian pesakit 
diabetes mengikut GPK. Purata markah pengetahuan mereka adalah 23.6 (SD = 3.41) 
daripada jumlah 30 atau 78. 7%, median markah sikap adalah 29 (IQR = 8) daripada 
jumlah 35 atau 82.9% dan median markah amalan adalah 27 (IQR = 4) daripada jumlah 
30 atau 90%. 
Sejumlah 208 pesakit diabetes dengan kawalan glukosa yang tidak baik menyertai 
kajian ini. Purata markah amalan mereka adalah 21.9 {SD = 2.49) daripada jumlah 32 
atau 68.4%, median markah pengetahuan adalah 42 (IQR = 8) daripada jumlah 48 atau 
87.5% dan median markah sikap adalah 14 (IQR = 2) daripada jumlah 15 atau 93.3%. 
Pesakit yang berkahwin, tidak menerima pendidikan formal dan menerima rawatan 
diabetes di KK yang tidak mempunyai Pakar Perubatan Keluarga (PPK) mempunyai 
paras HbA1c yang lebih tinggi. Paras glukosa darah berpuasa juga meningkat secara 
bermakna dengan meningkatnya paras HbA1c-
Sejumlah 88 orang peserta PKD dari kumpulan intervensi dan 55 orang dari kumpulan 
kawalan menyempumakan kajian ini. Di dalam kumpulan intervensi, peningkatan yang 
bermakna di dalam markah pengetahuan mereka dapat diperhatikan berbanding 
kumpulan kawalan. Sejumlah 86 orang peserta pesakit dari setiap kumpulan 
... 
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menyempurnakan kajian ini. Markah amalan mereka menurun lebih banyak di dalam 
kumpulan intervensi daripada kumpulan kawalan. 
KESIMPULAN 
Kebanyakan peserta PKD di Kelantan mengetahui tentang adanya GPK diabetes. 
Walaubagaimanapun, penggunaan GPK di kalangan mereka adalah kurang memuaskan. 
PSA PKD dan pesakit adalah agak baik tetapi ianya tidak membawa kepada kawalan 
diabetes yang baik kepada pesakit. Faktor-faktor yang berkaitan dengan paras HbA1c di 
dalam pesakit ini adalah paras glukosa darah berpuasa, taraf pendidikan dan 
perkahwinan serta menerima rawatan di KK yang mempunyai PPK. Kursus intensif 
yang dijalankan cuma berjaya memperbaiki markah pengetahuan PKD secara minima. 
Kemungkinan kursus intensif sehari yang diberikan tidak mencukupi untuk mengubah 
PSA ahli-ahli PKD dan pendidikan berstruktur yang berterusan perlu untuk memberi 
penekanan tentang PSA kepada PKD. Tempoh masa empat bulan mungkin tidak 
mencukupi bagi PKD menguruskan pesakit mereka dengan baik bagi memberikan 




A Study On The Use Of Clinical Practice Guidelines (CPG) On Management of Type 2 
Diabetes Mellitus In Kelantan. 
INTRODUCTION 
The prevalence of diabetes is increasing in Malaysia. Majority of the patients were 
reported to have poor glycaemic control. CPG were developed to improve the practice 
of health care providers for better health outcomes in patients. 
OBJECTIVE 
The objective of this study was to determine the use of diabetic CPG among diabetes 
care team (DCT), to evaluate the effectiveness of intensive training on the CPG given to 
DCT in Kelantan on their knowledge, attitude and practice (KAP) and patients' KAP 
and diabetic control, and to determine the factors associated with HbAtc levels in type 2 
diabetic patients with poor control in Kelantan. 
METHODS 
This study was conducted in all health centres (HC) in Kelantan from August 2005 till 
March 2006. Cross-sectional study design was used to determine the characteristics of 
DCT and their use of diabetic CPG, and the characteristics of type 2 diabetic patients 
with poor control and the factors associated with their HbAtc levels. To determine the 
effect of intensive course on diabetic CPG given to DCT on their KAP and their 
patients' KAP and diabetic control, randomised controlled trial was used where the 
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participants were randomized into intervention and control group by cluster according 
to the districts in Kelantan. The participants were all DCT members and diabetic 
patients with poor control. Post-intervention data were collected four months after the 
intervention was completed. 
RESULTS 
A total of 176 DCT members participated in this study. Most of the participants knew 
about the existence of diabetic CPG (79. 5%) or have ever read it (71. 6% ). In term of the 
use of CPG, only 40.4% to 83.1% of them claimed always practice according to the 
diabetes care measured. The mean total knowledge scores were 23.6 marks (SD = 3.41) 
from the total score of 30 or 78. 7%, and the median total attitude and practice scores 
were 29 (IQR = 8) from the total score of 35 and 27 marks (IQR = 4) from the total 
score of30 or 82.9% and 90%, respectively. 
A total of 208 diabetic patients with poor control participated in this study. Their mean 
total practice scores were 21.9 (SD = 2.49) from the total score of 32 or 68.4%, and the 
median of total knowledge and attitude scores were 42 (IQR = 8) from the total score of 
48 and 14 (IQR = 2) from the total score of IS or 87.5% and 93.3%, respectively. 
Patients who were married, had no formal education and receiving their diabetic care in 
HC without Family Medicine Specialist (FMS) were significantly associated with 
poorer HbAtc levels. Fasting blood glucose (FBG) levels were significantly increased 
with increasing levels ofHbAtc· 
A total of 88 DCT participants in intervention and 55 in control group completed this 
study. In the intervention group, significant improvement was observed in knowledge 
XVl 
scores as compared to control group. A total of 86 patient participants in each group 
completed this study. Their practice scores were significantly reduced more in 
intervention compared to control group. However the changes observed here were 
minimal. No significant changes were observed in all the other outcome variables 
measured in DCT or patient participants. 
CONCLUSION 
Majority of the DCT members in Kelantan knew about the existence of diabetic CPG. 
However, their use of the CPG was not very satisfactory. The KAP ofDCT and patients 
were quite good but that did not translate into good diabetic control of the patients. 
Factors associated with HbAtc levels in the diabetic patients with poor control FBG, 
educational level, marital status and receiving care in HC with FMS. After intervention, 
significant improvement was only seen in the knowledge score ofDCT, albeit minimal. 
One day intensive course may not be enough to change DCT' s KAP and regularly 
structured continuing medical education (CME) might be needed to reinforce their 
KAP. Four months duration may not be enough for the DCT to properly manage their 
diabetic patients for observable changes in the patients' KAP and diabetic control 
measures. 
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1 INTRODUCTION AND LITERATURE REVIEW 
1.1 Diabetes Mellitus 
Diabetes mellitus {DM) is a group of metabolic diseases characterized by a chronic 
hyperglycaemic state and disturbances of carbohydrate, fat and protein metabolism. It is 
caused by insufficient or absence of the hormone insulin, or defect in the insulin action 
or insulin resistance, or both (WHO, 1994, WHO, 1999, Gavin et a/., 2003). The 
disease has high morbidity and mortality. High cost is needed in order to manage it, in 
monetary terms or socially, to the patients, their family or to the health care providers 
and government (Olsson eta/., 1994, AACE, 2002). 
Diseases with clinical features of diabetes have been recognized since 1550 BC, noted 
from the ancient Egyptian papyrus discovered by George Ebers (Ekoe et a/., 2001 ). The 
word 'diabetes' is a Greek word, meaning siphon. In the 181h century Matthew Dobson, 
a Liverpool physician, showed that the sweetness of urine and serum was caused by 
sugar (Ekoe eta/., 2001, Williams and Pickup, 2004). John Rollo (1809) was the first to 
use the word 'mellitus', a Greek and Latin word for 'honey' as an adjective for 
'diabetes' (Williams and Pickup, 2004). In 1889, Oskar Minkowski and Joseph von 
Mering showed that pancreas disorder caused diabetes (Williams eta/., 2002). In 1869, 
Paul Langer hans found 'islets of Langer hans' which was later known to produce the 
glucose-lowering hormone, 'insulin' (from Latin word, 'insuline' meaning island) 
-(Williams and Pickup, 2004). 
1 
1.1.1 Diagnosis anti classifications of diabetes mellitus 
Diagnosis of DM can be made in: 
1. Subjects with signs and symptoms of diabetes, with random plasma glucose 
of more or equal to 11.1 mmoVL 
2. Subjects with fasting plasma glucose (FPG) of more or equal to 7.0 mmol/L. 
3. Subjects whose two hours plasma glucose after oral glucose tolerance test 
(OGTT) using 75 gram load of glucose given by mouth were more or equal 
to 11.1 mmol/L. 
In the absence of unequivocal hyperglycaemia with acute metabolic decompensation, 
each method above should be confirmed on a different day by any method (ADA, 
2006). The detail values for diagnosis ofDM and other categories of hyperglycaemia is 
shown in appendix A. 
The classification ofDM was previously classified based on clinical descriptive criteria 
as recommended by the 1985 WHO Study Group (WHO, 1994) and according to the 
pharmacological treatment used in the management of the disease (Gavin eta/., 2003). 
Classification into insulin-dependent DM (IDDM), non-insulin-dependent DM 
(NIDDM) and a few other categories were widely accepted at that time (WHO, 1994). 
Currently, DM is classified according to the aetiology of the disease, resulted from 
improved understanding of the causes ofDM into type 1 diabetes, type 2 diabetes, other 
specific types of diabetes such as genetic defects of B-cell or insulin function, drug-
induced or chemical-induced and infections, and gestational diabetes (WHO, 1999). 
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1.1.2 Epidemiology of diabetes mellitus 
DM is one of the commonest chronic non-communicable diseases globally. The 
prevalence varies in different geographic regions and in different ethnic groups, ranging 
from zero in rural Melanesia (highland population of Papua New Guinea) to 40% in 
Micronesians (Nauru) and more than 50% in population of Pima Indians of the United 
States. The prevalence ofDM in Europe vary from 1.6% in Northern Ireland to 4.7% in 
Malta (Ismail and Gill, 1999). DM is epidemic in many developing and newly 
industrialized countries and the fourth or fifth leading cause of death in most developed 
nations. It has been referred to as pandemic due to its rapid increase in incidence 
globally. Type 2 DM is more common and constitutes about 85 to 95% of all diabetes in 
developed countries and even higher in developing countries (King eta/., 1995, Ekoe et 
a/., 2001, IDF, 2003, Taylor, 2004). 
The prevalence ofDM in Malaysia is steadily increasing, from 0.6% in 1960, to 2.1% in 
1982. The first National Health Morbidity Survey (NHMS) done in 1986 reported the 
prevalence of diabetes in Malaysia was 6.3% (Bakri eta/., 1999, Zaini, 2000, Shafie 0. 
eta/., 2004, MOH, 2003). The second NHMS in 1996 reported higher prevalence of 
8.3% (5. 7% known and 2.5% undiagnosed diabetics). Based on that prevalence, it was 
estimated that there was a total of700,000 to 900,000 persons with diabetes in Malaysia 
in 1999 and this figure is expected to increase to two million cases by the year 2025 
(MOH, 1998, MOH, 2003, Shafie 0. eta/., 2004). The prevalence in Kelantan from 
NHMS 11 was only 5.3% (3.3% known and 2.0% unknown diabetics) (Bakri eta/., 
1999). However, Mafauzy et a!. (1999) reported the prevalence of DM in Kelantan as 
3 
high as 10.5o/o. The difference seen could be due to difference in sampling and diagnosis 
method, and source population. 
Diabetes admission to government hospitals in Malaysia has increased from 19,629 
cases in 1991 to 30,661 cases in 2001. The diabetes mortality has increased from 254 
deaths in 1991 to 3 80 deaths in 2001 (MOH, 2003, Shafie 0. et a/., 2004). Similar trend 
was observed in Kelantan. The admission to government hospitals due to DM has 
increased from 954 cases in 1996 to 1828 cases in 2002, with 90% increment within six 
years. The number of new diabetes cases in health centres (HC) in Kelantan increased 
from 4,787 cases in 1998 to 6,904 cases in 2002 which constitutes about 44% increment 
in four years (JKNK, 2003b ). 
The first burden of disease results produced for Malaysia by Institute for Public Health 
reported DM as the sixth DAL Ys in male and fifth in female in 2000. In 2000, there 
were 47 060 DALYs for DM or 2.9% of the total DALYs in male and 56,390 DALYs 
' 
for DM or 4.6% of the total DAL Ys in female in Malaysia. DM is the third cause of 
years lived with disability (YLD) in Malaysia in 2000, in both male and female. DM 
constituted about 34,750 YLD or 6.0% of the total YLD in male and 37.631 YLD or 
7.2% of the total YLD in female (Ahmad Faudzi eta/., 2005). 
4 
Glycaemic control in Malaysia and Kelantan 
Majority of diabetic patients in Malaysi~ or Kelantan had poor glycaemic control. 
Diabetes Care Data Collection Project (DCDCP), a survey-study done in 1997 on 
diabetes management and complication status in Asian countries reported the mean 
HbAtc in Malaysia was 9.1%. Only 12% of the patients had good glycaemic control 
with HbAtc of less than 6.5%, meaning majority or 88% of Malaysian diabetic patients 
had poor glycaemic control. The mean FBG also showed similar trend with the mean of 
10.4 mmol!L with 86% ofthem had FBG levels of above 6.1% (DCDCP, 1997). 
In Kelantan, a study done in Hospital Universiti Sains Malaysia (HUSM) showed 73% 
of type 2 diabetic patients had HbAtc levels of more than 7%, and 60% had FBG levels 
of above 7.2 mmol!L. The worst glycaemic control were seen in Malays with HbA1c 
levels of 8.7% (Eid eta/., 2003). Another study done in Kelantan also showed poor 
glycaemic control in diabetic patients where 85.7% had HbAtc levels of more than 7.5% 
and mean HbA1c levels of9.9% (Suhaiza eta/., 2004). The study however was done in 
one district in Kelantan only and may not be representative of the whole Kelantan. 
Kelantan State Department of Health (Jabatan Kesihatan Negeri Kelantan or JKNK) 
reported 61.1% of diabetic patients from HC in Kelantan had HbAtc levels of more than 
8% in the year 2003 and 86% had HbA1c levels of above 6.5% in 2004 (JKNK, 2003a, 
JKNK, 2004). The figure may not be truly representative of Kelantan due to purposive 
selection of patients to whom the HbAtc measurements were done in clinical setting. 
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1.1.3 Management and complications of type 2 diabetes 
The management of type 2 DM must not only address the glycaemic control, but also 
other CVD risk factors such as dyslipidaemia, hypertension and obesity (Asian-Pacific 
Type 2 Diabetes Policy Group, 2002). Holistic approach of management by treating the 
whole person is important in diabetic patients because DM is a life-long disease and can 
cause a lot of complications if not managed properly (Mohamad Taha et a/., 2004). 
Currently there are four available classes of oral hypoglycaemic agents (OHA), namely 
biguanides, insulin secretagogues, alpha-glucosidase inhibitors and thiazolidinediones. 
Insulin is indicated in type 2 diabetic patients whose hyperglycaemia was not well 
controlled on maximum doses of combinations OHA or as initial therapy in those who 
have significant hyperglycaemia (Dailey, 2004). Just recently, on the 1 ih October 2006, 
the USA Food and Drug Administration (FDA) approved a new class of OHA, 
sitagliptin phosphate (Januvia™). It is a dipeptidyl peptidase IV inhibitors which can 
enhance the body's own ability to lower elevated blood sugar (FDA, 2006, Januvia, 
2006). 
DM is the leading cause of blindness, renal failure and non-traumatic lower limb 
amputation. Chronic hyperglycaemia, even without symptoms, will lead to tissue 
damage in many organ systems such which can cause serious complications and can be 
fatal (IDF, 2003). Complications of type 2 DM can be classified into acute and chronic 
complications and the latter can be further divided into macrovascular and 
microvascular complications. 
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Acute complications of DM are hypo and hyperglycaemia. Hypoglycemia can be life-
threatening if not corrected. It may occur in diabetic patients if food intake 1s 
insufficient, delayed or omitted, insulin or sulphonylurea overdose, or if there IS 
increase in physical exercise. Diabetic ketoacidosis is caused by insulin deficiency, 
characterized by hyperglycaemia, hyperketonaemia and metabolic acidosis. Typically 
affecting young type I DM, it can be precipitated in type 2 diabetic patients during 
severe infections and other illnesses. Hyperosmolar non-ketotic hyperglycaemia is 
characterized by gradual development of marked hyperglycaemia with dehydration and 
prerenal uraemia, without significant ketosis and acidosis. It usually occurs in middle-
aged or elderly type 2 diabetic patients and relatively uncommon but carries high 
mortality, particularly in the elderly (Williams and Pickup, 2004). 
DM can cause increase in atherosclerotic disease of large vessels, including cardiac, 
cerebral and peripheral vascular disease, or CVD, which are its macrovascular 
complications (Nathan, 1993, Ekoe et a/., 2001 ). CVD is the most common cause of 
mortality and morbidity and accounts for up to 65% of deaths in people with type 2 DM 
(WHO, 1994, Diabetes NSF Team, 2002). The UKPDS has shown that for each 1% 
increment in HbA1c levels, there was an increased risk of 11% in the occurrence of 
CHD (Turner eta/., 1998). 
The chronic complications that are specific to diabetes include retinopathy, nephropathy 
and neuropathy, which are the microvascular complications. Diabetic retinopathy is 
characterized by varying degree of microaneurysms, haemorrhages, exudates, venous 
changes, new vessels formation and retinal thickening. It can involve the peripheral 
retina, the macula or both. It can lead to blindness, the most feared but preventable 
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microvascular complications of DM (Harding, 2003, Watkins, 2003a). Diabetic 
nephropathy occurs in 25-40% of diabetic patients within 20-25 years of the onset of 
DM (Strippoli et a/.~ 2004). Peripheral neuropathy is commonest in diabetic patients, 
causing painful neuropathy, disabling foot ulcers, and death from autonomic neuropathy 
(Hughes, 2002). It occurs in approximately 60-70% of diabetic patients (Dailey, 2004). 
Neuropathy and ischaemia are the main underlying disorders of diabetic foot problems. 
Ulcers can be secondarily infected by bacteria and if confounded by ischaemic foot, the 
risk for gangrene is high and could lead to amputation (Watkins, 2003b). 
1.1. 4 Diabetes program in Malaysia 
Diabetes program has long been in the health care service in Malaysia but it was not 
very well coordinated. A National Diabetes Prevention and Control Program was 
initiated by the Ministry of Health Malaysia (MOH) in 1996 to improve the DM 
program in Malaysia. Later in 1998, the National Diabetes Care Seminar, organized by 
MOH, Malaysian Endocrine and Metabolic Society (MEMS) and Malaysian Diabetes 
Association or Persatuan Diabetes Malaysia (PDM) has highlighted several issues 
which had then been incorporated into the national program. Structured diabetes clinics 
and diabetes resource centre has been established in all public hospitals. Green diabetes 
card has been introduced to be used by all diabetic patients to improve record keeping. 
Besides record keeping, the card can be used as a guideline to educate diabetic patients. 
It has essential information in diabetes care~ e.g. the treatment given, target for diabetic 
control, presence of complications etc. Paramedics has been given greater role and 
responsibility in managing diabetic patients. They were trained in preventive and 
diabetes care, also to work as diabetes care team (OCT), together with medical officers 
8 
(MOH, 2003, Shafie 0. et al., 2004). Training of DCT members was usually done 
regularly by the local health authority about once or twice each year. The training was 
not concentrated on diabetic CPG alone but incorporated into a one or two days general 
course on non-communicable diseases or CVD. 
Reorganization of the National Diabetes Program in 2000 has given emphasis on health 
promotion and education, diabetes screening, diabetes care management and 
monitoring, screening for complications, training, recording, monitoring and 
involvement of non-governmental organisations (NGOs). NGOs involved with diabetes 
care in Malaysia are MEMS, PDM, Nutrition Society of Malaysia, Dietician Society of 
Malaysia and National Diabetes Institute (NADI). Health promotion and education is 
important as primary prevention. Therefore, emphasis has been given on the importance 
of promoting healthy lifestyle and behaviour through the use of media publicity 
campaigns and production and distribution of educational materials. Opportunistic 
screening, especially for the high risk group has been conducted since 1996 and found 
to be useful. In 2002, 18% of cases had been found to have definite abnormal readings 
(MOH, 2003, Shafie 0. et al., 2004). Diabetes care management and monitoring is 
important in view of findings from DCCT and UKPDS which had shown delay in the 
onset of the diabetic complications with intensive glycaemic control (DCCT Research 
Group, 1993, Stratton eta/., 2000). To facilitate the early detection for complications, 
MOH has introduced the microalbumin testing kit and fundus camera in government 
hospitals and HC. Training of health personnel, especially DCT members was seen as a 
crucial component in the National Diabetes Program because successful disease 
prevention needs not only motivated but also knowledgeable health personnel (MOH, 
2003, Shafie 0. et al., 2004). 
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1.2 Clinical Practice Guideline (CPG) 
1. 2.1 Definition and purposes 
Oxford Advanced Learner's Dictionary of Current English and The New Oxford 
American Dictionary defined the word "guideline" as "a general rule, instruction or 
piece of advice" (Hornby, 1995, Jewel and Abate F. (eds), 2001). Oxford Reference 
English Dictionary defined it as "a principle or criterion guiding or directing action" 
(Pearsal and Trumble B. (eds), 2002). Similarly, Merriam-Webster's Collegiate 
Dictionary defines guideline as "an indication or outline of policy or conduct" (Mish F. 
C. et al (eds), 1996). 
Clinical practice guideline (CPG) was defined by WHO as "systematically developed 
statements to assist providers and users of health services to make decisions about 
appropriate health care for specific circumstances" (WHO, 2001). An online 
encyclopedia defines CPG as a document with the aim of guiding decisions and criteria 
in specific areas of healthcare using evidence-based medicine. It could include 
summarized consensus statements and also address practical issues in the health care 
(Wikipedia Encyclopedia, 2006). 
There are many CPG circulating worldwide on many topics, including CPG on the 
management of DM. Many countries has their own CPG on topics which were 
important or relevant to their countries. In the United States of America (USA) alone, 
there are a few CPG on the management of DM, produced or published by the 
American Diabetes Association (ADA, 2002), the American Association of Clinical 
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Endocrinologists (AACE, 2002), the Veterans Health Administration (Clark et a/., 
2000) and the American Geriatric Society (Olson and Norris, 2004). 
The use and value ofCPG goes back even to the time ofPlato (360 BC). The CPG then 
were more of consensus-based until about thirty years ago when it becoming more 
evidence-based and put most weight on evidences produced by RCT. A comparative 
analysis of diabetes CPG from 13 countries (Australia, Canada, Denmark, England, 
Finland, France, Italy, The Netherlands, New Zealand, Scotland, Spain, Switzerland and 
USA) showed that the CPG were in agreement about the general management of type 2 
DM and there was overlapped in the evidence cited with 18% of citations shared with 
any other CPG. Research originating from the USA predominated ( 40% of citations) but 
nearly all the CPG were more likely to cite evidence from their own countries (Burgers 
et al., 2002). 
The aims of CPG are to promote the best practices and raise quality of care. This can 
assist in achieving better health outcomes or outcomes of treatment by improving the 
practice of health care providers. It is also hoped to increase patients' awareness of the 
options available for the management of specific conditions (Haycox et a/., 1999, 
MOH, 2003, Wikipedia Encyclopedia, 2006). Some ofthe other purposes ofCPG are to 
standardize the medical care and reduce the inappropriate variation in practice, to 
provide a more rational basis for referral and a focus for continuing education, to 
promote efficient use of resources and to achieve the best balance between cost and 
clinical practice. CPG can also act as focus for quality control, including audit (Zaleski 
et a/., 1997, MOH, 2003, Open Clinical, 2006, Wikipedia Encyclopedia, 2006). 
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Mandatory practice guidelines has also been introduced as a way of cost containment, as 
being done in France (Zaleski et al., 1997). 
The objectives of CPG can only become reality if the outcomes identified in RCT are 
reproducible in normal practice and there is rapid and universal adoption of the CPG 
which leads to optimal treatment for the whole population. Local evidence therefore is a 
priority to be used in CPG (Burgers eta/., 2002). However, in clinical practice in the 
community, resources are more restricted, patients are less compliance and treatment 
cannot be limited to a small group of patients. Due to that, the anticipated benefits are 
rarely fully realised (Haycox eta/., 1999). 
1.2.2 CPG on type 2 DM in Malaysia 
In Malaysia, CPG have been produced since 1992 under the responsibility of the Health 
Care Quality Unit of the Medical Development Division under MOH. In 2001, with 
reorganization in the MOH, it came under the purview of the Health Technology 
Assessment Unit (MOH, 2003). Many CPG developed in Malaysia are available on 
various topics, examples are on management of chronic obstructive pulmonary disease 
(Zainudin et a/., 1998), management of heart failure (Rajadurai et a/., 2000), 
management of obesity (Ikram Shah eta/., 2004) and others. 
The specific CPG for management of type 2 DM was published in 1997 under the 
Diabetes Info Series by MOHand PDM (MOHand PDM, 1997). It has been revised 
and the newest revised edition is only recently become available for use (CPG Task 
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Force, 2004). It focused on screening and diagnosis, management of type 2 DM and its 
chronic complications, and prevention of type 2 DM. It is meant to be a guide for 
clinical practice, based on the best available evidence at the time of its development 
(CPG Task Force, 2004). Targets for control in the management of type 2 DM 
according to the CPG is as listed in table 1 below. 









Body mass index (BMI) 
Blood Pressure (BP) 
Normal renal function 




4.4- 8.0 mmol/L 
<6.5% 
< 1.7 mmol/L 
:=: 1. 1 mmoVL 
:::; 2.6 mmol/L 
< 23 kglm2 
:S 130/80 mm!Hg 
:S 120/75 mm!Hg 
Adapted (CPG Task Force, 2004) 
1.2.3 Effect of CPG-based intervention 
(a) Effect on diabetic care processes 
A before and after study done to assess the impact of the publication of the ADA CPG 
on diabetes showed no significant improvement in the diabetic patient care as 
anticipated, except in the areas of foot care, eye examination and lipid screening (Stolar, 
1995). Later the ADA CPG on diabetes has been implemented through a series of 
lectures for all the primary care providers and the distribution of "tool-kits" to all points 
of care. CPG adherence was also encouraged at regular departmental meetings. The 
before and after study done to assess the effectiveness of the implementation showed 
significant increase only in the percentages of patients receiving yearly microalbumin 
screens and recommended education, however no significant improvement in the other 
processes of care evaluated (Lesho et a/., 2005). 
An RCT done in general practices in east London where the locally developed diabetic 
CPG disseminated through practice based education and multidisciplinary educational 
outreach or academic detailing showed significant improvements in recording of all the 
key variables in patient records (Feder eta/., 1995). 
(b) Effect on diabetic outcome 
The sudy by Lesho eta/. (2005) mentioned above also measure the HbA1c levels in the 
diabetic patients as an outcome, but found no significant change in the mean HbA1c 
levels before and after the implementation of the diabetic CPG. Benjamin eta/. (1999) 
however noted significant improvement in HbA1c levels after CPG training of their 
staffs based on Staged Diabetes Management in a problem-based learning program. 
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1.3 Conceptual framework 
Socio-demographic 
factors: 




to medication and 
healthy lifestyles 




















treatment to patients 
Figure 1: Conceptual framework of factors associated with diabetic control 
From the above conceptual framework, this study is expected to ascertain the 
sociodemographic and compliance factors associated with glycaemic control in diabetic 
patients with poor control. Intensive course on diabetic CPG g iven to DCT is expected 
Glycaemic control in diabetic patients is a complex and multifactorial function of the 
patients' factors and health care providers' factors (figure 1). Patients' factor associated 
with glycaemic control can be divided into socio-demographic and other factors and 
adherence to medication and healthy lifestyle. Many previous studies done on factors 
associated with glycaemic control reported conflicting results. This could be due to the 
difference in the source population and methodology used, categorisation of the 
patients' characteristics, and the difference in the classification of poor and good 
glycaemic control. 
a) Socio-demographic factors 
Studies done in Indiana and HUSM showed that younger age group was associated with 
poorer glycaemic control type 2 diabetic patients (Nichols eta!., 2000, Eid eta/., 2003), 
but reverse association was found in another study (Ferrannini eta/., 1992). However, 
no significant association was found in a few other studies (Blaum et a/., 1997, Suhaiza 
eta/., 2004). 
Many studies done found no significant association between sex and glycaemic control 
(Ferrannini eta/., 1992, Blaum eta/., 1997, Eid eta/., 2003, Suhaiza eta/., 2004). 
However, Nichols eta!. (2000) found that male sex predicted worse glycaemic control. 
Studies done in the USA found significantly higher HbAtc concentrations in blacks as 
compared to whites (Schectman eta/., 2002, Rekeneire eta/., 2003). Eid eta/. (2003) 
observed worst glycaemic control in Malay type 2 diabetic patients compared to non-
Malay subjects. No significant association between poor glycaemic control and 
educational level was found in a secondary analysis of data by Blaum eta/. (1997). 
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Suhaiza et al. (2004) found no association between marital status and glycaemic 
control. Better marital satisfaction or good quality of marriage was found to be related 
to higher levels of diabetes-related satisfaction and better general quality of life. The 
same study found non-significant but strong trend relating good glycaemic control to 
good marriages, but no relationship was found between intimacy and glycaemic control 
(Trief et a/., 2001). It might be difficult to demonstrate an effect for any specific 
psychosocial variable in view of numerous factors affecting glycaemic control. 
b) Other factors 
Studies by Blaum eta/. (1997) and Eid eta/. (2003) showed that longer duration ofDM 
was significantly associated with poorer glycaemic control, however no significant 
association was found in study by Suhaiza et al. (2004). No significant association 
between BMI and glycaemic control was found in studies done by Ferrannini eta/. 
( 1992), Blaum et a/. ( 1997), Eid et a/. (2003) and Suhaiza et a/. (2004 ), though obesity 
was deemed as one of the important risk factor for the development of type 2 DM. 
A meta-analysis of 24 studies reported association between depression and 
hyperglycaemia in patients with type 1 and type 2 DM (Lustman eta/., 2000). Study 
done by Blaum et a/. ( 1997) showed significant independent association between poor 
self-care ability and perceived absence of dietary recommendations with poor glycaemic 
control. The self care ability scale was based on questions to evaluate patients' ability to 
comply with diet, exercise and medication and their ability to cope with the demands of 
DM. Poorer HbA1c levels was also found to be associated with higher SF-36 Bodily 
Pain subscale score and low physical functioning subscale score (Sinnott et a/., 2005). 
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c) Adherence to medication and healthy lifestyle 
A retrospective study done by Rhee eta/. (2005) showed that there was a significant 
improvement in the glycaemic control in patients with high adherence level to keeping 
appointments and taking medications as directed. Study by Schectman et al. (2002) also 
found better metabolic control with greater medication adherence. 
High dietary fiber intake has been shown to improve blood glucose and HbA1c levels, 
decrease hyperinsulinaemia, lower plasma lipid concentrations and the number of 
hypoglycaemic events in type 1 and type 2 diabetic patients (Chandalia et a/., 2000, 
Giacco eta/., 2000). Low glycaemic index diet has a therapeutic potential in type 2 DM 
and has been shown to lower the glucose and insulin responses throughout the day 
while improving the glucose utilization by the body, lipid profile and fibrinolytic 
activity, as measured by the PAI-l activity (Jarvi eta/., 1999, Rizkalla eta/., 2004). 
Low levels of physical activity were found to be associated with poor glycaemic control 
in type 1 diabetic women (Waden et a/., 2005). On the other hand, high-intensity 
resistance training, in combination of moderate weight loss was found to be effective in 
improving g1ycaemic control in older patients with type 2 DM (Dunstan et a/., 2002). 
SMBG has been associated with better glycaemic control among type 2 diabetic patients 
on insulin therapy (Franciosi et al., 2001, Murata et al., 2003). A systematic review of 
randomised controlled trial also reported an overall significant improvement in the 
HbA1c levels in type 2 diabetic patients not on insulin using SMBG compared to 
control, with the decrease of0.39% in HbAlc (Welschen et al., 2005). 
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2 OBJECTIVES AND RESEARCH QUESTIONS 
2.1 General objective 
To determine the use of diabetic CPG among DCT in managing type 2 diabetic patients 
in Kelantan 
2.2 Specific objectives 
1. To determine the use of CPG on management of type 2 DM among DCT 
members in Kelantan and their KAP on the CPG. 
2. To determine the characteristics of type 2 diabetic patients with poor control in 
Kelantan and factors associated with their HbA1c levels. 
3. To evaluate the effectiveness of intensive refresher course on CPG on DM given 
to DCT members in Kelantan on their KAP on the CPG, compared to those 
without the intensive course. 
4. To evaluate the effect of the above intensive revision course given to DCT on 
patients' KAP about diabetes and its management and their diabetic control 
compared to patients with the usual care. 
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2.3 Research hypothesis 
I. The use of diabetic CPG among DCT in Kelantan and their KAP is high. 
2. There is improvement in KAP of DCT in Kelantan after being given intensive 
refresher course on diabetic CPG compared to control group. 
3. There is improvement in KAP and diabetic control of diabetic patients' under 
the DCT's care who were being given intensive refresher course on diabetic 
CPG as compared to usual care. 
4. There is association between socio-demographic and clinical factors and KAP of 
diabetic patients with poor control in Kelantan with their HbA1c levels. 
2.4 Rationale of the study 
1. CPG were developed to decrease the practice variation among the health care 
providers and hoped to assist in achieving better health outcomes of the patients 
by improving the practice of the health care providers. However, many experts 
acknowledge the uncertainty of the effectiveness of CPG but still encourage 
their implementation (Lesho et al., 2005). 
2. JKNK acknowledged that use of CPG among DCT was not satisfactory (JKNK, 
2003b ), but no formal study was done before to determine that fact. 
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3. Not many studies were done to determine the effect of training of diabetic CPG 
on DCT' s KAP and diabetic control of patients with type 2 DM. 
4. To comply to the Western Pacific Declaration on Diabetes who encourage 
research to advance and apply knowledge about the effective management of 
diabetes (Asian-Pacific Type 2 Diabetes Policy Group, 2002). 
5. To comply to WHO recommendation about the need to do intervention research 
on different models of care for diabetes in different societies (WHO, 1994). 
6. Finding the factors associated with poorly controlled diabetic patients can give 
insight in the management of the patients to give better care for better diabetic 
control. 
7. Study on patients' KAP is still important because current approach in 
management of DM is towards self-management. To be able to do that, the 
patients must have good knowledge and attitude about DM and its management. 
This can contribute to good practice among the patients towards their disease 
and its management. 
8. Study on DCT KAP is also important because health care providers involved in 
the management of diabetic patients must have good knowledge and attitude 
about DM and its management, which can then improve their practice towards 
the disease and its management in order to give appropriate care and 
management for the patients. 
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2.5 Definition of terms 
Term Definition 
CPG A systematically developed statements to assist providers and 
users of health services to make decisions about appropriate 






Metabolic control which was needed to be monitored in a 
diabetic patient as an appropriate management of DM to prevent 
or delay the development of diabetic complications, which is 
HbA1c and I or FBG. Other related control are fasting lipid 
profile (FLP), BP and BMI 
Interdisciplinary group of care providers, including Family 
Medicine Specialist (FMS), Medical and Health Officer 
(M&HO), medical assistants (MA), nurses and medical 
laboratory technician (ML T), responsible in taking care of 
diabetic patients, counseling them in all aspect of their disease 
management and empowering them for self-management (King 
eta/., 1995) 
The effects of the activity and the end-results, outcomes or 
benefits for the population achieved in relation to the stated 
objectives (King et al., 1995) 
Blood glucose level which is measured from the serum. The 
blood is taken after the patient has fasted overnight or for about 
8-16 hours, during which plain water may be drunk 
Used to measure the levels of cholesterol components, including 
TC, TG, HDL and LDL in the blood. The blood is taken after 
the patient has fasted overnight or for about 8-16 hours because 










type 2 diabetic 
patients 
Definition 
The measure of blood glucose level m diabetic patients, 
measured by HbAtc levels 
Also known as glycaeted haemoglobin or glycohaemoglobin, 
HbAtc measures the amount of glucose that has bonded with the 
haemoglobin in red blood cells which is formed slowly and non-
enzymatically. It gives the average blood glucose levels over the 
past two or three months because the average survival of the red 
blood cells was 120 days( Goldstein eta/., 2004, Roberts, 2004) 
A program, procedure, service or activity which is carried out to 
improve or maintain health, health behaviours or other factors 
associated with health (WHO, 2001) 
A revision course during which all the related knowledge and 
practicalities were given in a short period of time, which was 
one day only instead of a longer, extensive course 
Knowledge, attitude and practice about a certain matter which 
was measured using a specially constructed questionnaire which 
was validated prior to its usage 
Type 2 diabetic patients who had poor glycaemic control with 
the HbAtc levels of more than 6.5% (Asian-Pacific Type 2 
Diabetes Policy Group, 2002, CPG Task Force, 2004) 
23 
3 MATERIALS AND METHODS 
3.1 Study area 
This study was done in Kelantan, one ofthe states in Malaysia. It is situated at the east 
coast of Peninsular Malaysia (figure 2) with the total population of 1,479,800 people 
(MOH, 2004). It consists of ten ' Jajahan ' or administrative districts, namely Kota 
Bharu, Bachok, Pasir Puteh, Machang, Tanah Merah, Jeli, Kuala Krai, Tumpat, Pasir 
Mas and Gua Musang (figure 3). Every district has its own District Health Office, under 
the administration of a Medical Officer of Health. Some District Health Office has a 
second Medical Officer of Health or Epidemiology Officer to assist the principal 
Medical Officer of Health. To cater for the population, every district has a few health 
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